Palliative hypnosis approaches in the symptomatic treatment of amyotrophic lateral sclerosis (ALS)

被引:1
|
作者
Franklin, John E. [1 ,2 ]
机构
[1] Med Univ South Carolina, Charleston, SC USA
[2] Med Univ South Carolina, Dept Vet Affairs, Med Ctr, POB 12728, Charleston, SC 29422 USA
关键词
ALS; amyotrophic lateral sclerosis; hypnosis; palliative; SEVERE CHRONIC DISEASES; OF-LIFE; CLINICAL HYPNOSIS; DIGNITY THERAPY; ANXIETY; CARE; END; DEPRESSION; EXPERIENCE;
D O I
10.1080/00029157.2023.2252875
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a rare, incurable, and ultimately fatal, devastating, progressive degenerative neurologic disease. It causes upheaval in the lives of patients and family caregivers alike. Palliative care can play an important supportive role in the care of patients and families dealing with the devastation of this illness. Clinical hypnosis has demonstrated benefits in treating the symptoms associated with severe chronic illness. There are, however, few studies looking at the benefits of clinical hypnosis in treating the symptom burden of ALS. This article describes palliative care and how it can provide an additional layer of support to seriously ill patients. A brief review of previous studies of hypnosis in the supportive, symptomatic treatment of ALS is provided, followed by a description of a case series of 30 Veterans who received clinical hypnosis and self-hypnosis training as a complementary treatment for the symptoms of ALS. Details of three case histories are included to highlight and discuss specific strategies and emblematic clinical responses. There is evidence that clinical hypnosis can benefit ALS patients and family caregivers struggling with this devastating illness.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] L-THREONINE AS A SYMPTOMATIC TREATMENT FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    ROUFS, JB
    MEDICAL HYPOTHESES, 1991, 34 (01) : 20 - 23
  • [2] Ventilatory support and palliative care in amyotrophic lateral sclerosis (ALS)
    Gonzalez-Bermejo, Jesus
    Hurbault, Amelie
    Coupe, Christophe
    Meininger, Vincent
    Similowski, Thomas
    MEDECINE PALLIATIVE, 2010, 9 (06): : 309 - 317
  • [3] ADVANCES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    Andreadou, E.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3197 - 3198
  • [4] Speech Therapy in Palliative Therapy Settings: Amyotrophic Lateral Sclerosis (ALS)
    Regelmann, Eva-Maria
    Beushausen, Ulla
    SPRACHE-STIMME-GEHOR, 2022, 46 (01): : 41 - 43
  • [5] Amyotrophic lateral sclerosis (ALS)
    Silani, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 4 - 4
  • [6] Stem cells in the treatment of amyotrophic lateral sclerosis (ALS)
    Silani, V
    Fogh, I
    Ratti, A
    Sassone, J
    Ciammola, A
    Cova, L
    AMYOTROPHIC LATERAL SCLEROSIS, 2002, 3 (04): : 173 - 181
  • [7] Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis
    McGeer, EG
    McGeer, PL
    BIODRUGS, 2005, 19 (01) : 31 - 37
  • [8] Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis
    Edith G. McGeer
    Patrick L. McGeer
    BioDrugs, 2005, 19 : 31 - 37
  • [9] POLIOVIRUS AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    GANN, KL
    VIOLA, MV
    CLINICAL RESEARCH, 1978, 26 (04): : A626 - A626
  • [10] Amyotrophic Lateral Sclerosis(ALS):Will There Be A Cure?
    GUAN Teng
    ZHANG Xiao-sha
    ZHOU Ting
    WANG Yu-tian
    孔吉明
    神经药理学报, 2019, 9(Z1) (Z1) : 28 - 30